共 50 条
- [2] Court strikes down FDA restrictions on dissemination of information about off-label uses - Judge notes that some such uses "constitute the standard of good medical care" [J]. BIOTECHNOLOGY LAW REPORT, 1998, 17 (05): : 595 - 596
- [4] FDA publishes final rule on off-label information [J]. ONCOLOGY-NEW YORK, 1999, 13 (02): : 150 - 150
- [5] Implications of Regulatory Policies on Off-Label Uses for Industry Competitiveness [J]. Drug information journal : DIJ / Drug Information Association, 1998, 32 (2): : 379 - 381
- [6] Implications of regulatory policies on off-label uses for industry competitiveness [J]. DRUG INFORMATION JOURNAL, 1998, 32 (02): : 379 - 381
- [7] FDA SCRUTINIZES OFF-LABEL PROMOTIONS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (01): : 11 - 11
- [8] DISSEMINATION OF INFORMATION ON THE OFF-LABEL (UNAPPROVED) USE OF MEDICATION: A COMPARATIVE ANALYSIS [J]. MEDICINE AND LAW, 2011, 30 (01): : 115 - 132